Vascular smooth muscle cell peroxisome proliferator-activated receptor-γ deletion promotes abdominal aortic aneurysms

Journal of Vascular Surgery

Volumn 52, Issue 4, 2010, Pages 984-993

  Hamblin, Milton ^a   Chang, Lin ^a   Zhang, Hengmin ^a   Yang, Kun ^a   Zhang, Jifeng ^a   Chen, Y Eugene ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CALCIUM CHLORIDE; CATHEPSIN S; ELASTIN; GLYCOPROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN F4 80; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CATHEPSIN;

ABDOMINAL AORTA; ABDOMINAL AORTA ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA WALL; ARTERY DILATATION; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA RESPONSIVE ELEMENT; ENZYME ACTIVATION; GENE DELETION; GENE OVEREXPRESSION; GENE SEQUENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; WILD TYPE; ANIMAL; AORTIC ANEURYSM, ABDOMINAL; BINDING SITE; CELL CULTURE; CHEMICALLY INDUCED; DEFICIENCY; DISEASE MODEL; GENETIC TRANSFECTION; GENETICS; INFLAMMATION; LESIONS AND DEFECTS; METABOLISM; PATHOLOGY; RNA INTERFERENCE; TIME; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; BINDING SITES; CALCIUM CHLORIDE; CATHEPSINS; CELLS, CULTURED; DILATATION, PATHOLOGIC; DISEASE MODELS, ANIMAL; ELASTIN; ENZYME ACTIVATION; INFLAMMATION; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PPAR GAMMA; PROMOTER REGIONS, GENETIC; RATS; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 77957571909     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.05.089     Document Type: Article

References (47)

1. National Center for Health Statistics (NHCS) NVSS, WISQARS (Web-Based Injury Statistics Query and Reporting System) Query: 20 leading causes of death, United States 1999-2006. All races, male and female sexes 2009 Centers for Disease Control and Prevention Atlanta
2. C.B. Ernst Abdominal aortic aneurysm N Engl J Med 328 1993 1167 1172
3. J. Powell, and R.M. Greenhalgh Cellular, enzymatic, and genetic factors in the pathogenesis of abdominal aortic aneurysms J Vasc Surg 9 1989 297 304
4. N. Marx, T. Bourcier, G.K. Sukhova, P. Libby, and J. Plutzky PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease Arterioscler Thromb Vasc Biol 19 1999 546 551
5. N. Marx, U. Schonbeck, M.A. Lazar, P. Libby, and J. Plutzky Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells Circ Res 83 1998 1097 1103
6. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
7. M. Hamblin, L. Chang, Y. Fan, J. Zhang, and Y.E. Chen PPARs and the cardiovascular system Antioxid Redox Signal 11 2009 1415 1452
8. S. Lim, C.J. Jin, M. Kim, S.S. Chung, H.S. Park, and I.K. Lee PPARgamma gene transfer sustains apoptosis, inhibits vascular smooth muscle cell proliferation, and reduces neointima formation after balloon injury in rats Arterioscler Thromb Vasc Biol 26 2006 808 813
9. D. Meredith, M. Panchatcharam, S. Miriyala, Y.S. Tsai, A.J. Morris, and N. Maeda Dominant-negative loss of PPARgamma function enhances smooth muscle cell proliferation, migration, and vascular remodeling Arterioscler Thromb Vasc Biol 29 2009 465 471
10. L. Chang, L. Villacorta, J. Zhang, M.T. Garcia-Barrio, K. Yang, and M. Hamblin Vascular smooth muscle cell-selective peroxisome proliferator-activated receptor-gamma deletion leads to hypotension Circulation 119 2009 2161 2169
11. C.M. Halabi, A.M. Beyer, W.J. de Lange, H.L. Keen, G.L. Baumbach, and F.M. Faraci Interference with PPAR gamma function in smooth muscle causes vascular dysfunction and hypertension Cell Metab 7 2008 215 226
12. G. Hansmann, V.A. de Jesus Perez, T.P. Alastalo, C.M. Alvira, C. Guignabert, and J.M. Bekker An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension J Clin Invest 118 2008 1846 1857
13. N. Wang, G. Yang, Z. Jia, H. Zhang, T. Aoyagi, and S. Soodvilai Vascular PPARgamma controls circadian variation in blood pressure and heart rate through Bmal1 Cell Metab 8 2008 482 491
14. M. Schupp, J. Janke, R. Clasen, T. Unger, and U. Kintscher Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity Circulation 109 2004 2054 2057
15. B.S. Brooke, J.P. Habashi, D.P. Judge, N. Patel, B. Loeys, and H.C. Dietz 3rd Angiotensin II blockade and aortic-root dilation in Marfan's syndrome N Engl J Med 358 2008 2787 2795
16. J.M. Lehmann, L.B. Moore, T.A. Smith-Oliver, W.O. Wilkison, T.M. Willson, and S.A. Kliewer An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) J Biol Chem 270 1995 12953 12956
17. L. Villacorta, F.J. Schopfer, J. Zhang, B.A. Freeman, and Y.E. Chen PPARgamma and its ligands: therapeutic implications in cardiovascular disease Clin Sci (Lond) 116 2009 205 218
18. A. Jones, R. Deb, E. Torsney, F. Howe, M. Dunkley, and Y. Gnaneswaran Rosiglitazone reduces the development and rupture of experimental aortic aneurysms Circulation 119 2009 3125 3132
19. J. Golledge, B. Cullen, C. Rush, C.S. Moran, E. Secomb, and F. Wood Peroxisome proliferator-activated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysm Atherosclerosis 210 2010 51 56
20. G.M. Longo, W. Xiong, T.C. Greiner, Y. Zhao, N. Fiotti, and B.T. Baxter Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms J Clin Invest 110 2002 625 632
21. K. Yoshimura, H. Aoki, Y. Ikeda, K. Fujii, N. Akiyama, and A. Furutani Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase Nat Med 11 2005 1330 1338
22. J. Sun, G.K. Sukhova, M. Yang, P.J. Wolters, L.A. MacFarlane, and P. Libby Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice J Clin Invest 117 2007 3359 3368
23. M. Fu, J. Zhang, Y.H. Tseng, T. Cui, X. Zhu, and Y. Xiao Rad GTPase attenuates vascular lesion formation by inhibition of vascular smooth muscle cell migration Circulation 111 2005 1071 1077
24. L. Villacorta, J. Zhang, M.T. Garcia-Barrio, X.L. Chen, B.A. Freeman, and Y.E. Chen Nitro-linoleic acid inhibits vascular smooth muscle cell proliferation via the Keap1/Nrf2 signaling pathway Am J Physiol Heart Circ Physiol 293 2007 H770 H776
25. J. Zhang, M. Fu, X. Zhu, Y. Xiao, Y. Mou, and H. Zheng Peroxisome proliferator-activated receptor delta is up-regulated during vascular lesion formation and promotes post-confluent cell proliferation in vascular smooth muscle cells J Biol Chem 277 2002 11505 11512
26. G.K. Sukhova, Y. Zhang, J.H. Pan, Y. Wada, T. Yamamoto, and M. Naito Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice J Clin Invest 111 2003 897 906
27. H. Abdul-Hussien, R.G. Soekhoe, E. Weber, J.H. von der Thusen, R. Kleemann, and A. Mulder Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases Am J Pathol 170 2007 809 817
28. G.P. Shi, G.K. Sukhova, A. Grubb, A. Ducharme, L.H. Rhode, and R.T. Lee Cystatin C deficiency in human atherosclerosis and aortic aneurysms J Clin Invest 104 1999 1191 1197
29. M. Wassef, B.T. Baxter, R.L. Chisholm, R.L. Dalman, M.F. Fillinger, and J. Heinecke Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute J Vasc Surg 34 2001 730 738
30. H.L. Keen, M.J. Ryan, A. Beyer, S. Mathur, T.E. Scheetz, and B.D. Gackle Gene expression profiling of potential PPARgamma target genes in mouse aorta Physiol Genomics 18 2004 33 42
31. A.E. Koch, G.K. Haines, R.J. Rizzo, J.A. Radosevich, R.M. Pope, and P.G. Robinson Human abdominal aortic aneurysms Immunophenotypic analysis suggesting an immune-mediated response Am J Pathol 137 1990 1199 1213
32. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
33. H.A. Chapman, R.J. Riese, and G.P. Shi Emerging roles for cysteine proteases in human biology Annu Rev Physiol 59 1997 63 88
34. D. Bromme, P.R. Bonneau, P. Lachance, B. Wiederanders, H. Kirschke, and C. Peters Functional expression of human cathepsin S in Saccharomyces cerevisiae Purification and characterization of the recombinant enzyme J Biol Chem 268 1993 4832 4838
35. G.K. Sukhova, and G.P. Shi Do cathepsins play a role in abdominal aortic aneurysm pathogenesis? Ann NY Acad Sci 1085 2006 161 169
36. S. Anidjar, P.B. Dobrin, M. Eichorst, G.P. Graham, and G. Chejfec Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysms J Vasc Surg 16 1992 139 147
37. K. Shimizu, R.N. Mitchell, and P. Libby Inflammation and cellular immune responses in abdominal aortic aneurysms Arterioscler Thromb Vasc Biol 26 2006 987 994
38. W. Xiong, J. MacTaggart, R. Knispel, J. Worth, Y. Persidsky, and B.T. Baxter Blocking TNF-alpha attenuates aneurysm formation in a murine model J Immunol 183 2009 2741 2746
39. R.W. Thompson, D.R. Holmes, R.A. Mertens, S. Liao, M.D. Botney, and R.P. Mecham Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages J Clin Invest 96 1995 318 326
40. W.D. McMillan, B.K. Patterson, R.R. Keen, V.P. Shively, M. Cipollone, and W.H. Pearce In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta Arterioscler Thromb Vasc Biol 15 1995 1139 1144
41. N. Marx, G. Sukhova, C. Murphy, P. Libby, and J. Plutzky Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro Am J Pathol 153 1998 17 23
42. F. Meisner, D. Walcher, F. Gizard, X. Kapfer, R. Huber, and A. Noak Effect of rosiglitazone treatment on plaque inflammation and collagen content in nondiabetic patients: data from a randomized placebo-controlled trial Arterioscler Thromb Vasc Biol 26 2006 845 850
43. R. de Nooijer, I. Bot, J.H. von der Thusen, M.A. Leeuwenburgh, H.S. Overkleeft, and A.O. Kraaijeveld Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis Arterioscler Thromb Vasc Biol 29 2009 188 194
44. Y. Yasuda, Z. Li, D. Greenbaum, M. Bogyo, E. Weber, and D. Bromme Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages J Biol Chem 279 2004 36761 36770
45. T. Freestone, R.J. Turner, D.J. Higman, M.J. Lever, and J.T. Powell Influence of hypercholesterolemia and adventitial inflammation on the development of aortic aneurysm in rabbits Arterioscler Thromb Vasc Biol 17 1997 10 17
46. P.D. Home, S.J. Pocock, H. Beck-Nielsen, R. Gomis, M. Hanefeld, and N.P. Jones Rosiglitazone evaluated for cardiovascular outcomesan interim analysis N Engl J Med 357 2007 28 38
47. S.E. Nissen, and K. Wolski Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes N Engl J Med 356 2007 2457 2471